Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review

BACKGROUND: Infants < 3 months of age are at highest risk for developing severe complications after pertussis. The majority of pregnant women has low concentrations of pertussis-specific antibodies and thus newborns are insufficiently protected by maternally transferred antibodies. Acellular pert...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Infect Dis
Glavni autori: Vygen-Bonnet, Sabine, Hellenbrand, Wiebke, Garbe, Edeltraut, von Kries, Rüdiger, Bogdan, Christian, Heininger, Ulrich, Röbl-Mathieu, Marianne, Harder, Thomas
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7020352/
https://ncbi.nlm.nih.gov/pubmed/32054444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-4824-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items